scispace - formally typeset
Open AccessJournal ArticleDOI

Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning.

Daniel J. Drucker
- 02 Mar 2021 - 
- Vol. 33, Iss: 3, pp 479-498
TLDR
The increased prevalence of obesity, diabetes, and cardiovascular risk factors in people hospitalized with severe COVID-19 illness has engendered considerable interest in the metabolic aspects of SARS-CoV-2-induced pathophysiology as mentioned in this paper.
About
This article is published in Cell Metabolism.The article was published on 2021-03-02 and is currently open access. It has received 145 citations till now. The article focuses on the topics: Diabetes mellitus.

read more

Citations
More filters
Journal ArticleDOI

A Calculator for COVID-19 Severity Prediction Based on Patient Risk Factors and Number of Vaccines Received

TL;DR: A model estimating the probabilities for hospitalization and mortality according to individual risk factors and vaccine doses received could help prioritize vaccination and yet scarce medications to maximize lives saved and reduce the burden on hospitalization facilities.
Journal ArticleDOI

The Endocrine Adipose Organ: A System Playing a Central Role in COVID-19

Francesca Cinti, +1 more
- 01 Jul 2022 - 
TL;DR: This mini-review aims to retrace the adipose organ history from physiology to physiopathology, to provide therapeutic perspectives for the prevention and treatment of its two main related diseases, mainly obesity and type 2 diabetes and to summarize the most recent discoveries linking adipose tissue to COVID-19.
Journal ArticleDOI

ACE2 polymorphisms impact COVID-19 severity in obese patients

TL;DR: In this article , the expression of angiotensin converting enzyme 2 (ACE2), the main receptor for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is enhanced in obese individuals.
Journal ArticleDOI

Towards Goals to Refine Prophylactic and Therapeutic Strategies Against COVID-19 Linked to Aging and Metabolic Syndrome.

TL;DR: In this paper, the authors examined the prevalence and molecular mechanisms underlying enhanced risk of COVID-19 in elderly people and individuals with metabolic syndrome (MetS), which is primarily derived from obesity-induced systemic chronic low-grade inflammation with numerous complications, including type 2 diabetes mellitus.
Journal ArticleDOI

Multifaceted entrancing role of glucose and its analogue, 2-deoxy-D-glucose in cancer cell proliferation, inflammation, and virus infection.

TL;DR: 2-DG as mentioned in this paper is a modified form of D-glucose, that shows anticancer, anti-inflammatory, and anti-viral effects, and it is converted into 2-deoxy-D-GLucose-6-phosphate with the help of hexokinase.
References
More filters
Journal ArticleDOI

Dexamethasone in Hospitalized Patients with Covid-19

TL;DR: In patients hospitalized with Covid-19, the use of dexamethasone resulted in lower 28-day mortality among those who were receiving either invasive mechanical ventilation or oxygen alone at randomization but not among those receiving no respiratory support.
Related Papers (5)